Patent · US Expired

Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same

US6265161A · kind A · utility

0Cited by

1References

7Claims

0Family size

Assignee

Institut Pasteur and Institut National de la Sante et de la Recherche Medicale · FR

Inventors

Anne Dejean · Paris, FR
Marie-Annick Buendia · Le Perreux-sur-Marne, FR
Pascal Pineau · Paris, FR
Hisaki Nagai · Tokyo, JP

Key dates

Filing date	Apr 6, 1998
Grant date	Jul 24, 2001
Priority date	—
Expiry date	Apr 6, 2018

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A method for detecting a predisposition to hepatocellular carcinoma (HCC) using a unique panel of primers for identifying genetic alterations that are linked to HCC, as well as kits for carrying out the methods, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.